BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22674506)

  • 21. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
    Joshi AD; Hegde GV; Dickinson JD; Mittal AK; Lynch JC; Eudy JD; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5295-304. PubMed ID: 17875758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia.
    Pekova S; Cmejla R; Smolej L; Kozak T; Spacek M; Prucha M
    Leuk Res; 2008 Mar; 32(3):395-400. PubMed ID: 17688945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia.
    Trbusek M; Smardova J; Malcikova J; Sebejova L; Dobes P; Svitakova M; Vranova V; Mraz M; Francova HS; Doubek M; Brychtova Y; Kuglik P; Pospisilova S; Mayer J
    J Clin Oncol; 2011 Jul; 29(19):2703-8. PubMed ID: 21606432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance.
    Zucchetto A; Sonego P; Degan M; Bomben R; Dal Bo M; Russo S; Attadia V; Rupolo M; Buccisano F; Steffan A; Del Poeta G; Pucillo C; Colombatti A; Campanini R; Gattei V
    J Immunol Methods; 2005 Oct; 305(1):20-32. PubMed ID: 16198366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
    Kalla C; Scheuermann MO; Kube I; Schlotter M; Mertens D; Döhner H; Stilgenbauer S; Lichter P
    Eur J Cancer; 2007 May; 43(8):1328-35. PubMed ID: 17449237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.
    Boonstra JG; van Lom K; Langerak AW; Graveland WJ; Valk PJ; Kraan J; van 't Veer MB; Gratama JW
    Cytometry B Clin Cytom; 2006 May; 70(3):136-41. PubMed ID: 16568475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cluster analysis of immunophenotypic data: the example of chronic lymphocytic leukemia.
    Zucchetto A; Cattarossi I; Nanni P; Zaina E; Prato G; Gilestro M; Marconi D; Bulian P; Rossi FM; Del Vecchio L; Omedè P; Geuna M; Del Poeta G; Gattei V
    Immunol Lett; 2011 Jan; 134(2):137-44. PubMed ID: 20923685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.
    Strefford JC; Sutton LA; Baliakas P; Agathangelidis A; Malčíková J; Plevova K; Scarfó L; Davis Z; Stalika E; Cortese D; Cahill N; Pedersen LB; di Celle PF; Tzenou T; Geisler C; Panagiotidis P; Langerak AW; Chiorazzi N; Pospisilova S; Oscier D; Davi F; Belessi C; Mansouri L; Ghia P; Stamatopoulos K; Rosenquist R
    Leukemia; 2013 Nov; 27(11):2196-9. PubMed ID: 23558524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of sucrase-isomaltase mutations from chronic lymphocytic leukemia patients.
    Rodríguez D; Ramsay AJ; Quesada V; Garabaya C; Campo E; Freije JM; López-Otín C
    Hum Mol Genet; 2013 Jun; 22(11):2273-82. PubMed ID: 23418305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
    Vollbrecht C; Mairinger FD; Koitzsch U; Peifer M; Koenig K; Heukamp LC; Crispatzu G; Wilden L; Kreuzer KA; Hallek M; Odenthal M; Herling CD; Buettner R
    PLoS One; 2015; 10(6):e0129544. PubMed ID: 26053404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.
    Wang L; Brooks AN; Fan J; Wan Y; Gambe R; Li S; Hergert S; Yin S; Freeman SS; Levin JZ; Fan L; Seiler M; Buonamici S; Smith PG; Chau KF; Cibulskis CL; Zhang W; Rassenti LZ; Ghia EM; Kipps TJ; Fernandes S; Bloch DB; Kotliar D; Landau DA; Shukla SA; Aster JC; Reed R; DeLuca DS; Brown JR; Neuberg D; Getz G; Livak KJ; Meyerson MM; Kharchenko PV; Wu CJ
    Cancer Cell; 2016 Nov; 30(5):750-763. PubMed ID: 27818134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.
    Ferreira PG; Jares P; Rico D; Gómez-López G; Martínez-Trillos A; Villamor N; Ecker S; González-Pérez A; Knowles DG; Monlong J; Johnson R; Quesada V; Djebali S; Papasaikas P; López-Guerra M; Colomer D; Royo C; Cazorla M; Pinyol M; Clot G; Aymerich M; Rozman M; Kulis M; Tamborero D; Gouin A; Blanc J; Gut M; Gut I; Puente XS; Pisano DG; Martin-Subero JI; López-Bigas N; López-Guillermo A; Valencia A; López-Otín C; Campo E; Guigó R
    Genome Res; 2014 Feb; 24(2):212-26. PubMed ID: 24265505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes.
    Calin GA; Croce CM
    Blood; 2009 Nov; 114(23):4761-70. PubMed ID: 19745066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Development and Use of Scalable Systems for Studying Aberrant Splicing in SF3B1-Mutant CLL.
    Murthy T; Paul KV; Minella AC; Pillai MM
    Methods Mol Biol; 2019; 1881():83-99. PubMed ID: 30350199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion.
    Aalto Y; El-Rifa W; Vilpo L; Ollila J; Nagy B; Vihinen M; Vilpo J; Knuutila S
    Leukemia; 2001 Nov; 15(11):1721-8. PubMed ID: 11681413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep sequencing in cancer research.
    Yoshida K; Sanada M; Ogawa S
    Jpn J Clin Oncol; 2013 Feb; 43(2):110-5. PubMed ID: 23225907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overlapped differentially expressed genes between acute lymphoblastic leukemia and chronic lymphocytic leukemia revealed potential key genes and pathways involved in leukemia.
    Zhang S; Zhang Q; Yin J; Wu X
    J Cell Biochem; 2019 Sep; 120(9):15980-15988. PubMed ID: 31081970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Factors in the Era of Targeted Therapies in CLL.
    Boddu P; Ferrajoli A
    Curr Hematol Malig Rep; 2018 Apr; 13(2):78-90. PubMed ID: 29473123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.
    Sutton LA; Rosenquist R
    Haematologica; 2015 Jan; 100(1):7-16. PubMed ID: 25552678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.